News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Ron Alfa: Noetik and Agenus Announced an Exciting Collaboration to Deploy Foundation Models to Predict Immunotherapy Response
Ron Alfa/LinkedIn
Jun 19, 2025, 14:22

Ron Alfa: Noetik and Agenus Announced an Exciting Collaboration to Deploy Foundation Models to Predict Immunotherapy Response

Ron Alfa, Co-Foundar/CEO of NEOTIK, shared a post on LinkedIn:

“Today NOETIK and Agenus announced an exciting collaboration to deploy our virtual cell foundation models in the context of an active clinical program for the first time.
We know that Noetik models can learn patient biology, and predict which patients will respond to approved drugs such as anti-PD1. Together with Agenus, we’ll test capabilities of our models to enrich responders for the BOT/BAL program.
Predicting clinical success is the most critical bottleneck in bringing new medicines to patients. Today, we’re directing the most advanced foundation models in translational medicine at this challenging problem.”

Learn More.

Read Further.

Agenus Presented New Translational Data at the ASCO 2025

Agenus Names Leading GI Oncologist Dr. Richard Goldberg as Chief Development Officer

Agenus Bets Big on Botensilimab

agenus botensilimab fda

Agenus cancer Noetik OncoDaily Oncology Ron Alfa
Special Coverage
Insight
Jun 19, 2025, 14:22
Ron Alfa: Noetik and Agenus Announced an Exciting Collaboration to Deploy Foundation Models to Predict Immunotherapy Response
Blog
Jun 19, 2025, 13:42
Raffaele Colombo: Preclinical development of DB-1419 published on Clinical Cancer Research AACR
Blog
Jun 19, 2025, 13:21
Mohamed Kharfan-Dabaja: Happy to Share Our Clinical Practice Recommendations in CLL on behalf of ASTCT
Oncolibrary
Jun 19, 2025, 13:13
New Paper Alert: KEYNOTE-689. Neoadjuvant and Adjuvant Pembrolizumab Improves Survival in Locally Advanced HNC
Blog
Jun 19, 2025, 13:04
Raul Cordoba Shared FOLL12 Trial on the Role of PET in Follicular Lymphoma
Oncolibrary
Jun 19, 2025, 13:01
Pancreatic Cancer Remission Rate: What Patients Should Know in 2025
Career
Jun 19, 2025, 12:40
Kristy Brown Received an $800,000 Grant Grom The V Foundation to Study How Obesity Impacts Cancer Research - KU Cancer Center
Science
Jun 19, 2025, 12:22
Justin Taylor: Happy to Share Our Latest Paper on XPO1 R749Q Mutations Online Ahead of Print in Cancer Research
Blog
Jun 19, 2025, 11:53
Yakup Ergün: Ivonescimab (PD-1 × VEGF) and Tarlatamab (DLL3 × CD3) are My Favorites Drugs For Lung Cancer - Even Better Ones Are Yet to Come
Blog
Jun 19, 2025, 10:28
Enrique Soto Perez de Celis on the Global Mission of CU Cancer Center's International Fellowship Program
Insight
Jun 19, 2025, 09:48
Nicholas Hornstein: Watching the Center of Gravity in Oncology Drug Development Move
Blog
Jun 19, 2025, 09:37
Majority of Americans Oppose Cuts to Medical Research Funding - AACR